Improvements in cancer staging with PET/CT: literature-based evidence as of September 2006
J Czernin, M Allen-Auerbach… - Journal of Nuclear …, 2007 - Soc Nuclear Med
PET/CT with 18 F-FDG is increasingly being used for staging, restaging, and treatment monitoring
for cancer patients. CT is still frequently used only for attenuation correction and lesion …
for cancer patients. CT is still frequently used only for attenuation correction and lesion …
Accuracy of PET/CT in characterization of solitary pulmonary lesions
SK Kim, M Allen-Auerbach, J Goldin… - Journal of Nuclear …, 2007 - Soc Nuclear Med
Characterization of a pulmonary lesion is a well-established indication for metabolic
imaging with 18 F-FDG. There is extensive literature on the use of PET and CT in the …
imaging with 18 F-FDG. There is extensive literature on the use of PET and CT in the …
Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
…, S Forman, C Brown, M Allen-Auerbach… - Science translational …, 2017 - science.org
High-grade gliomas are aggressive cancers that often become rapidly fatal. Immunotherapy
using CD8 + cytotoxic T lymphocytes (CTLs), engineered to express both herpes simplex …
using CD8 + cytotoxic T lymphocytes (CTLs), engineered to express both herpes simplex …
FDG-PET/CT imaging predicts histopathologic treatment responses after the initial cycle of neoadjuvant chemotherapy in high-grade soft-tissue sarcomas
MR Benz, J Czernin, MS Allen-Auerbach, WD Tap… - Clinical cancer …, 2009 - AACR
Purpose: In patients with soft-tissue sarcoma (STS), the early assessment of treatment responses
is important. Using positron emission tomography/computed tomography (PET/CT) with …
is important. Using positron emission tomography/computed tomography (PET/CT) with …
Quantitative F18‐fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign
…, SM Dry, WD Tap, MS Allen‐Auerbach… - … Journal of the …, 2010 - Wiley Online Library
BACKGROUND: Correct pretreatment classification is critical for optimizing diagnosis and
treatment of patients with peripheral nerve sheath tumors (PNSTs). The aim of this study was …
treatment of patients with peripheral nerve sheath tumors (PNSTs). The aim of this study was …
Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue …
…, WA Weber, WD Tap, M Allen-Auerbach… - Clinical Cancer …, 2008 - AACR
Purpose: Change in tumor size as classified by Response Evaluation Criteria in Solid Tumors
poorly correlates with histopathologic response to neoadjuvant therapy in patients with soft…
poorly correlates with histopathologic response to neoadjuvant therapy in patients with soft…
Impact of 68Ga-PSMA-11 PET/CT on the management of prostate cancer patients with biochemical recurrence
…, P Gupta, A Quon, MS Allen-Auerbach… - Journal of Nuclear …, 2018 - Soc Nuclear Med
In this prospective survey of referring physicians, we investigated whether and how 68 Ga-labeled
prostate-specific membrane antigen 11 ( 68 Ga-PSMA-11) PET/CT affects the …
prostate-specific membrane antigen 11 ( 68 Ga-PSMA-11) PET/CT affects the …
68Ga-PSMA-11 PET/CT interobserver agreement for prostate cancer assessments: an international multicenter prospective study
WP Fendler, J Calais, M Allen-Auerbach… - Journal of Nuclear …, 2017 - Soc Nuclear Med
The interobserver agreement for 68 Ga-PSMA-11 PET/CT study interpretations in patients
with prostate cancer is unknown. Methods: 68 Ga-PSMA-11 PET/CT was performed in 50 …
with prostate cancer is unknown. Methods: 68 Ga-PSMA-11 PET/CT was performed in 50 …
18F-FDOPA PET for differentiating recurrent or progressive brain metastatic tumors from late or delayed radiation injury after radiation treatment
KJ Lizarraga, M Allen-Auerbach, J Czernin… - Journal of Nuclear …, 2014 - Soc Nuclear Med
Brain metastases are frequently treated with radiation. It is critical to distinguish recurrent or
progressive brain metastases (RPBM) from late or delayed radiation injury (LDRI). The …
progressive brain metastases (RPBM) from late or delayed radiation injury (LDRI). The …
[PDF][PDF] SNMMI procedure standard/EANM practice guideline for SSTR PET: imaging neuroendocrine tumors
Somatostatin receptor (SSTR) imaging using PET has replaced scintigraphic imaging using
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …
111In-pentetreotide (OctreoScan), unless PET is unavailable. Several benefits of SSTR PET …